1-2 of 2
Wei Wang, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma

Siguo Hao, MD PhD, Jie Jin, MD PhD, Songfu Jiang, MD, Zonghai Li, MD PhD, Wenhao Zhang, MD PhD, Min Yang, MD PhD, Kang Yu, MD, Wei Wang, MDPhD, Linjun Chen, MD PhD, Haitao Meng, MD PhD, Mingxia He, MD, Jun Xiao, MD, Rong Tao, MD PhD, Xin Huang, MD PhD, Chongyun Xing, MD, Daijing Yuan, MD, Jianbo Wan, MD PhD, Shasha Wang, MD PhD, Lihui Dai, BS, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-140156
Published: 2020
Journal Articles

Results from Lummicar-1: A Phase 1 Study of Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT053) in Chinese Subjects with Relapsed and/or Refractory Multiple Myeloma

Wenming Chen, MD PhD, Chengcheng Fu, MD PhD, Zhen Cai, MD PhD, Zonghai Li, MD PhD, Huijuan Wang, MD PhD, Lingzhi Yan, MD PhD, Yin Wu, MD PhD, Xiaolan Shi, MD PhD, Wen Gao, MD, Shuang Yan, MD, Wei Wang, MDPhD, Xiaoyan Han, MD PhD, Gaofeng Zheng, MD PhD, Yanling Wen, MD, Jun Xiao, MD, Huamao Wang, PhD, Hong Ma, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–50.
https://doi.org/10.1182/blood-2020-140727
Published: 2020